Kim Soo-Youl相关文献与解析，生知库 | 链接生命科学的每一步

Pyun Woo Yang, Park Jae Hyung, Roh Jae Won, Jeon Dongkyu, Kim Jongwan, Paik Ji Eun, Cho Seok Chan, Park So Yeon, Lim Hocheol, Kim Hyungwoo, Jang Young Jin, Lee Jaehoon, Byun Jong Hwa, Son Dong Woo, Kim Soo-Youl, Guan Kun-Liang, Lee Won Dong, Gee Heon Yung, Lee Han-Woong, No Kyoung Tai, Choi Yu Suk, Hashimoto Tadayoshi, Yoshino Takayuki, Jeong Han-Sol, Namkung Wan, Nam Joo Hyun, Park Hyun Woo

代谢

发表日期：2026

文献求助收藏

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β

转谷氨酰胺酶2通过直接灭活GSK3β加剧卵巢癌的生存期延长

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-026-08447-0

Lee, Ho; Kang, Joon Hee; Kim, Hyun Jung; Heo, Kyun; Park, Mi Kyung; Park, Jeong Hwan; Lee, Byung Il; Yook, Jong In; Kim, Soo-Youl

Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated Autophagy

靶向原始分子伴侣克服癌症获得性耐药性：TG2介导的自噬

期刊:Biomolecules & Therapeutics

影响因子:3.2

doi:10.4062/biomolther.2025.247

N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.

N-苯基马来酰亚胺通过抑制SLC25A11诱导生物能量转换并抑制胶质母细胞瘤肿瘤球的肿瘤生长

期刊:Cancer Cell International

影响因子:6

doi:10.1186/s12935-025-03813-y

Cho Hye Joung, Yoo Jihwan, Choi Ran Joo, Lee Jae-Seon, Kim Ryong Nam, Park Junseong, Moon Ju Hyung, Kim Eui Hyun, Teo Wan-Yee, Chang Jong Hee, Kim Soo-Youl, Kang Seok-Gu

Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC

利用靶向脂质代谢组学分析胰腺导管腺癌患者血浆，提出诊断生物标志物候选物

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17182988

Han, Sung-Sik; Woo, Sang Myung; Lee, Jun Hwa; Kang, Joon Hee; Park, Sang-Jae; Lee, Woo Jin; Park, Hyeong Min; Chun, Jung Won; Kim, Su Jung; Yoo, Hyun Ju; Kim, Kyung-Hee; Kim, Soo-Youl

Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights

将杂交策略整合到吡啶-脲骨架中，用于新型抗癌药物的设计、合成和机理研究

期刊:Molecules

影响因子:4.6

doi:10.3390/molecules28134952

Godesi, Sreenivasulu; Nada, Hossam; Lee, Joohan; Kang, Joon-Hee; Kim, Soo-Youl; Choi, Yongseok; Lee, Kyeong

Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling

肺部驻留中性粒细胞的独特特征是由 PGE2/PKA/Tgm2 介导的信号通路维持的。

期刊:Blood

影响因子:23.1

doi:10.1182/blood.2021014283

Bae, Geon Ho; Kim, Ye Seon; Park, Ji Ye; Lee, Mingyu; Lee, Sung Kyun; Kim, Ji Cheol; Kim, Jang Gyu; Shin, Ye Ji; Lee, Ho; Kim, Soo-Youl; Bae, Yong-Soo; Zabel, Brian A; Kim, Hong Sook; Bae, Yoe-Sik

A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes

一种可能与糖尿病有关的早期胰腺癌血清标志物

期刊:Jnci-Journal of the National Cancer Institute

影响因子:7.2

doi:10.1093/jnci/djab191

Nam, Hoonsik; Hong, Soon-Sun; Jung, Kyung Hee; Kang, Sunmi; Park, Min Seok; Kang, Suyeon; Kim, Han Sun; Mai, Van-Hieu; Kim, Juyoung; Lee, Ho; Lee, Woohyung; Suh, Young Ju; Lim, Joo Han; Kim, Soo-Youl; Kim, Song Cheol; Kim, So Hun; Park, Sunghyouk

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres

醛脱氢酶和线粒体复合物 I 抑制剂与化疗药物替莫唑胺联合治疗胶质母细胞瘤肿瘤球的疗效

期刊:Molecules

影响因子:4.6

doi:10.3390/molecules26020282

Park, Hun Ho; Park, Junseong; Cho, Hye Joung; Shim, Jin-Kyoung; Moon, Ju Hyung; Kim, Eui Hyun; Chang, Jong Hee; Kim, Soo Youl; Kang, Seok-Gu

Reply to Krupenko et al. Comment on "Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382"

回复 Krupenko 等人对“Lee 等人，《ALDH1L1 功能丧失与苯乙双胍治疗联合降低 KRAS 驱动的肺癌肿瘤生长》，Cancers 2020, 12, 1382”的评论

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers13092238

Lee, Seon-Hyeong; Jeon, Yoon; Kang, Joon-Hee; Jang, Hyonchol; Hong, Kyeong-Man; Hong, Dongwan; Lee, Ho; Kim, Soo-Youl

Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.

营养物质的可用性决定了癌症代谢对非肿瘤药物的治疗反应。

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β

转谷氨酰胺酶2通过直接灭活GSK3β加剧卵巢癌的生存期延长

Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated Autophagy

靶向原始分子伴侣克服癌症获得性耐药性：TG2介导的自噬

N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.

N-苯基马来酰亚胺通过抑制SLC25A11诱导生物能量转换并抑制胶质母细胞瘤肿瘤球的肿瘤生长

Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC

利用靶向脂质代谢组学分析胰腺导管腺癌患者血浆，提出诊断生物标志物候选物

Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights

将杂交策略整合到吡啶-脲骨架中，用于新型抗癌药物的设计、合成和机理研究

Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling

肺部驻留中性粒细胞的独特特征是由 PGE2/PKA/Tgm2 介导的信号通路维持的。

A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes

一种可能与糖尿病有关的早期胰腺癌血清标志物

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres

醛脱氢酶和线粒体复合物 I 抑制剂与化疗药物替莫唑胺联合治疗胶质母细胞瘤肿瘤球的疗效

Reply to Krupenko et al. Comment on "Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382"

回复 Krupenko 等人对“Lee 等人，《ALDH1L1 功能丧失与苯乙双胍治疗联合降低 KRAS 驱动的肺癌肿瘤生长》，Cancers 2020, 12, 1382”的评论